| RS1131691443 |
KLHL41
|
Health Risk |
Likely pathogenic |
— |
| RS1131691444 |
ENG
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1131691450 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1131691452 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 13 |
| RS1131691459 |
SCN8A
|
Health Risk |
Likely pathogenic |
— |
| RS1131691460 |
TBX5
|
Health Risk |
Likely pathogenic |
— |
| RS1131691461 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1131691462 |
FRAS1
|
Health Risk |
Likely pathogenic |
— |
| RS1131691463 |
SHANK3
|
Health Risk |
Likely pathogenic |
— |
| RS1131691464 |
SHANK3
|
Health Risk |
Likely pathogenic |
— |
| RS1131691465 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1131691466 |
SCN2A
|
Health Risk |
Likely pathogenic |
— |
| RS1131691467 |
FBN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1131691468 |
CHRDL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1131691469 |
SHANK3
|
Health Risk |
Likely pathogenic |
— |
| RS1131691471 |
KRT5
|
Health Risk |
Likely pathogenic |
— |
| RS1131691472 |
PANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS1131691473 |
ITPR1
|
Health Risk |
Likely pathogenic |
— |
| RS1131691474 |
GLRA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary hyperekplexia, Hereditary hyperekplexia |
| RS1131691475 |
KCNJ2
|
Health Risk |
Likely pathogenic |
Andersen Tawil syndrome, Short QT syndrome type 3 |
| RS1131691476 |
STAT3
|
Health Risk |
Pathogenic/Likely pathogenic |
STAT3 gain of function, Hyper-IgE recurrent infection syndrome 1 |
| RS1131691477 |
SLC6A5
|
Health Risk |
Likely pathogenic |
— |
| RS1131691478 |
FBN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1131691479 |
FBN1
|
Health Risk |
Likely pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1131691480 |
MECP2
|
Health Risk |
Likely pathogenic |
— |
| RS1131691481 |
GABRB3
|
Health Risk |
Pathogenic |
Epilepsy, childhood absence |
| RS1131691482 |
ELN
|
Health Risk |
Likely pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS1131691483 |
GCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1131691484 |
PCNT
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS1131691485 |
SHANK3
|
Health Risk |
Likely pathogenic |
— |
| RS1131691486 |
HPRT1
|
Health Risk |
Likely pathogenic |
— |
| RS1131691487 |
CLCN5
|
Health Risk |
Likely pathogenic |
— |
| RS1131691488 |
DBT
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS1131691489 |
KCNB1
|
Health Risk |
Likely pathogenic |
— |
| RS1131691490 |
SPINK5
|
Health Risk |
Pathogenic |
Netherton syndrome, Ichthyosis linearis circumflexa |
| RS1131691491 |
TCTN2
|
Health Risk |
Likely pathogenic |
— |
| RS1131691492 |
NDUFS8
|
Health Risk |
Likely pathogenic |
— |
| RS1131691498 |
ACSF3
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS1131691499 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1131691500 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1131691503 |
KMT2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS1131691506 |
DAG1
|
Health Risk |
Likely pathogenic |
— |
| RS1131691508 |
ARID1B
|
Health Risk |
Likely pathogenic |
— |
| RS1131691509 |
PCDH19
|
Health Risk |
Pathogenic |
— |
| RS1131691511 |
EFTUD2
|
Health Risk |
Likely pathogenic |
— |
| RS1131691512 |
ANKRD11
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, ANKRD11-related disorder |
| RS1131691513 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Long QT syndrome |
| RS1131691514 |
MYH7
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1131691515 |
CHD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy 94, Inborn genetic diseases |
| RS1131691516 |
KAT6A
|
Health Risk |
Likely pathogenic |
— |
| RS1131691517 |
OTC
|
Health Risk |
Likely pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS1131691518 |
KCNQ2
|
Health Risk |
Pathogenic |
Complex neurodevelopmental disorder, Complex neurodevelopmental disorder |
| RS1131691523 |
UBR1
|
Health Risk |
Likely pathogenic |
Johanson-Blizzard syndrome, Johanson-Blizzard syndrome |
| RS1131691524 |
UBR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Johanson-Blizzard syndrome, Johanson-Blizzard syndrome |
| RS1131691526 |
VHL
|
Health Risk |
Likely pathogenic |
— |
| RS1131691528 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1131691535 |
KDM6A
|
Health Risk |
Likely pathogenic |
Cervical cancer, Cervical cancer |
| RS1131691536 |
SALL4
|
Health Risk |
Pathogenic |
— |
| RS1131691538 |
CCM2
|
Health Risk |
Pathogenic |
— |
| RS1131691539 |
TPP1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS1131691540 |
FOXG1
|
Health Risk |
Pathogenic |
FOXG1 disorder, FOXG1 disorder |
| RS1131691541 |
TP53
|
Health Risk |
Pathogenic |
— |
| RS1131691542 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1131691543 |
TTN
|
Health Risk |
Pathogenic |
— |
| RS1131691545 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1131691546 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS1131691547 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1131691548 |
CHD8
|
Health Risk |
Pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS1131691549 |
PAX6
|
Health Risk |
Pathogenic |
— |
| RS1131691550 |
CRYGC
|
Health Risk |
Pathogenic |
— |
| RS1131691551 |
CLCN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myotonia, autosomal recessive form |
| RS1131691552 |
TBC1D24
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 1 |
| RS1131691553 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1131691554 |
SOX9
|
Health Risk |
Pathogenic |
Camptomelic dysplasia, Camptomelic dysplasia |
| RS1131691555 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Classic or attenuated familial adenomatous polyposis |
| RS1131691556 |
AP4M1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 50, Hereditary spastic paraplegia 50 |
| RS1131691558 |
NPC1
|
Health Risk |
Pathogenic |
— |
| RS1131691559 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS1131691560 |
ANOS1
|
Health Risk |
Pathogenic |
— |
| RS1131691561 |
DSP
|
Health Risk |
Pathogenic/Likely pathogenic |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma, Arrhythmogenic right ventricular dysplasia 8 |
| RS1131691562 |
MYH7
|
Health Risk |
Pathogenic |
— |
| RS1131691563 |
AMPD2
|
Health Risk |
Pathogenic |
— |
| RS1131691564 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS1131691566 |
EDA
|
Health Risk |
Pathogenic |
— |
| RS1131691567 |
ACAT1
|
Health Risk |
Pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS1131691568 |
NR3C2
|
Health Risk |
Pathogenic |
— |
| RS1131691570 |
PAX6
|
Health Risk |
Pathogenic |
— |
| RS1131691571 |
DDX3X
|
Health Risk |
Pathogenic |
DDX3X-related disorder, DDX3X-related disorder |
| RS1131691572 |
FRAS1
|
Health Risk |
Pathogenic |
— |
| RS1131691574 |
AMPD2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1131691575 |
POLG
|
Health Risk |
Pathogenic |
Mitochondrial disease, Progressive sclerosing poliodystrophy |
| RS1131691576 |
GRIN1
|
Health Risk |
Likely pathogenic |
— |
| RS1131691577 |
MYH7
|
Health Risk |
Likely pathogenic |
— |
| RS1131691578 |
FBN1
|
Health Risk |
Likely pathogenic |
— |
| RS1131691579 |
HDAC8
|
Health Risk |
Likely pathogenic |
— |
| RS1131691580 |
ALDH7A1
|
Health Risk |
Likely pathogenic |
— |
| RS1131691581 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1131691583 |
IGF1R
|
Health Risk |
Likely pathogenic |
IGF1R-related disorder, IGF1R-related disorder |
| RS1131691584 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS1131691585 |
CTNNB1
|
Health Risk |
Likely pathogenic |
— |